Articles in section Mergers & Acquisitions
<< Licensing | 660 articles | Opinion & Analysis >> |
Pages 1 2 3 4 5 .. 66 | Next >> |
-
AstraZeneca Buys Fusion Pharmaceuticals for US$2 B
-
Gilead to Acquire CymaBay Therapeutics and its Liver Disease Drug for US$4.3 B
-
Sanofi Acquires Rare Disease Developer Inhibrx for up to US$2.2 B
-
Novartis to Acquire MorphoSys for US$2.9 B to Expand Oncology Pipeline
-
Merck & Co. to Acquire Harpoon Therapeutics for US$680 M
-
GSK Acquires Aiolos Bio for US$1.4 B
-
Bristol Myers Squibb Bolsters Pipeline with Two Multibillion-Dollar Acquisitions
-
Roche to Acquire Carmot Therapeutics for US$3.1 B
-
AbbVie to Buy Cerevel Therapeutics for US$8.7 B to Bolster Neuroscience Portfolio
-
AbbVie to Acquire ImmunoGen for US$10.1 B